Perceptive Advisors LLC Aldeyra Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
A detailed history of Perceptive Advisors LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 9,275,851 shares of ALDX stock, worth $45 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
9,275,851
Previous 9,275,851
-0.0%
Holding current value
$45 Million
Previous $30.7 Million
62.84%
% of portfolio
1.31%
Previous 0.89%
Shares
7 transactions
Others Institutions Holding ALDX
# of Institutions
117Shares Held
36.4MCall Options Held
196KPut Options Held
142K-
Knoll Capital Management, LLC Miami, FL5.48MShares$26.6 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$18.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$17.6 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.88MShares$9.12 Million0.24% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$5.41 Million0.0% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $283M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...